Advanced search
Publication Cover
HIV Clinical Trials Volume 11, 2010 - Issue 5
Submit an article Journal homepage
77
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

Impact on Health-Related Quality of Life of a Switch From Enfuvirtide to Raltegravir Among Multidrug-Resistant HIV-1–Infected Patients: A Randomized Open-Label Trial (EASIER-ANRS 138)

Thomas BouletINSERM SC10 Villejuif, FranceCorrespondence[email protected]
,
Juliette PavieDepartment of Infectious DiseasesAssistance Publique Hôpitaux de Paris, Saint-Louis Hospital, University of Paris VII Diderot, Paris, France
,
Isabelle CharreauINSERM SC10 Villejuif, France
,
Joséphine BraunINSERM SC10 Villejuif, France
,
Jacques ReynesDepartment of Infectious and Tropical DiseasesGuide Chauliac Hospital, Montpellier, France
,
Philippe MorlatDepartment of Internal Medicine and Infectious DiseasesSaint-André Hospital, Bordeaux, France
,
Lionel PirothDepartment of InfectiologyBocage Hospital, Dijon, France
,
Bruno SpireINSERM U379 Marseille, France
,
Jean-Michel MolinaDepartment of Infectious DiseasesAssistance Publique Hôpitaux de Paris, Saint-Louis Hospital, University of Paris VII Diderot, Paris, France
&
Jean-Pierre AboulkerINSERM SC10 Villejuif, France
 show all
Pages 283-293 | Published online: 06 Jan 2015

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Bruno Spire, Lella Nait-Ighil, Pascal Pugliese, Isabelle Poizot-Martin, Vincent Jullien, Anne-Geneviève Marcelin & Eric Billaud. (2017) Quality of life improvement in HIV-1 patients treated with raltegravir in a real-life observational study: RACING. HIV Clinical Trials 18:1, pages 1-16.
Read now
Eric M. Maiese, Phaedra T. Johnson, Tim Bancroft, Alyssa Goolsby Hunter & Albert W. Wu. (2016) Quality of life of HIV-infected patients who switch antiretroviral medication due to side effects or other reasons. Current Medical Research and Opinion 32:12, pages 2039-2046.
Read now
Mohammad Ashraf Chaudhary, Elamin H Elbasha, Ritesh N Kumar & Esther C Nathanson. (2011) Cost–effectiveness of raltegravir in HIV/AIDS. Expert Review of Pharmacoeconomics & Outcomes Research 11:6, pages 627-639.
Read now

Articles from other publishers (5)

Gianmaria BaldinArturo CicculloFrancesca LombardiAnna D'AngelilloAlex DusinaArianna EmiliozziDamiano FarinacciDavide MoscheseChiara PicarelliAlberto BorghettiSimona Di Giambenedetto. (2021) Short Communication: Comparing Lamivudine+Dolutegravir and Bictegravir/Emtricitabine/Tenofovir Alafenamide as Switch Strategies: Preliminary Results from Clinical Practice. AIDS Research and Human Retroviruses 37:6, pages 429-432.
Crossref
Wan-gang Gu, Denis Tsz-Ming Ip, Si-jie Liu, Joseph H. Chan, Yan Wang, Xuan Zhang, Yong-tang Zheng & David Chi-Cheong Wan. (2014) 1,4-Bis(5-(naphthalen-1-yl)thiophen-2-yl)naphthalene, a small molecule, functions as a novel anti-HIV-1 inhibitor targeting the interaction between integrase and cellular Lens epithelium-derived growth factor. Chemico-Biological Interactions 213, pages 21-27.
Crossref
Harleen Gakhar, Amanda Kamali & Mark Holodniy. (2013) Health-related Quality of Life Assessment after Antiretroviral Therapy: A Review of the Literature. Drugs 73:7, pages 651-672.
Crossref
Caitlin Lee Shamroe, Paul Brandon Bookstaver, Kristina E.E. Rokas & Sharon B. Weissman. (2012) Update on Raltegravir and the Development of New Integrase Strand Transfer Inhibitors. Southern Medical Journal 105:7, pages 370-378.
Crossref
Kristina EE Rokas, P Brandon Bookstaver, Caitlin L Shamroe, S Scott Sutton, Vanessa E Millisor, Jacquelyn E Bryant & Sharon B Weissman. (2012) Role of Raltegravir in HIV-1 Management. Annals of Pharmacotherapy 46:4, pages 578-589.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.